BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6190596)

  • 61. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
    Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
    J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression of Staphylococcus aureus Cowan I-induced immunoglobulin synthesis in vitro: discrimination between the presence of suppressor T cell precursors and effectors.
    Pryjma J; Pituch-Noworolska A; Flad HD; Ulmer AJ; Ernst M
    Clin Exp Immunol; 1986 Nov; 66(2):348-57. PubMed ID: 2949899
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    Damle NK; Childs AL; Doyle LV
    J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
    Reitan LJ; Closs O
    Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
    Fagnoni FF; Takamizawa M; Godfrey WR; Rivas A; Azuma M; Okumura K; Engleman EG
    Immunology; 1995 Jul; 85(3):467-74. PubMed ID: 7558137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suppressor T cell activation by human leukocyte interferon.
    Schnaper HW; Aune TM; Pierce CW
    J Immunol; 1983 Nov; 131(5):2301-6. PubMed ID: 6226738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Specificity study of PPD-reactive human T cell line and clones.
    Bach MA; Pennec JM; Flageul B; Wallach D; Cottenot F
    Immunol Lett; 1985; 9(2-3):81-5. PubMed ID: 2580782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Suppression of BCG cell wall induced delayed-type hypersensitivity by BCG pre-treatment. I. Induction of adherent suppressor cells by live BCG injection and their characterization.
    Kato K; Yamamoto KI; Kakinuma M; Ishihara C; Azuma I
    Immunology; 1981 Feb; 42(2):259-66. PubMed ID: 6450731
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.
    Makonkawkeyoon S; Kasinrerk W
    Clin Exp Immunol; 1989 Jun; 76(3):398-403. PubMed ID: 2665977
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accessory cell function of a lined macrophage in the induction of suppressor T cells in vitro.
    Nakamura RM; Nakamura Y; Nagayama A; Tokunaga T
    Surv Synth Pathol Res; 1985; 4(5-6):443-56. PubMed ID: 2944205
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of BCG on concanavalin A-induced suppressor cell activity and lymphocyte stimulation in stage I melanoma.
    Pehamberger H; Knapp W
    J Invest Dermatol; 1981 Jun; 76(6):502-5. PubMed ID: 6453908
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for a soluble lymphocyte factor in the transplacental transmission of T-lymphocyte responses to Mycobacterium leprae.
    Barnetson RS; Bjune G; Duncan ME
    Nature; 1976 Mar; 260(5547):150-1. PubMed ID: 768774
    [No Abstract]   [Full Text] [Related]  

  • 73. Suppressor cells induced by purified protein derivative of tuberculin (PPD): the suppression is mediated by cells that proliferate in response to stimulation with PPD.
    Sörén L
    Scand J Immunol; 1979; 10(2):171-8. PubMed ID: 158828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens.
    Valone SE; Rich EA; Wallis RS; Ellner JJ
    Infect Immun; 1988 Dec; 56(12):3313-5. PubMed ID: 3053456
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clonal priming of human lymphocytes with soluble microbial antigens: high-dose paralysis, restoration, and autologous leukocyte preference.
    Dattner AM; Levis WR
    Scand J Immunol; 1978; 8(5):403-12. PubMed ID: 364628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interferon as a mediator of human lymphocyte suppression.
    Kadish AS; Tansey FA; Yu GS; Doyle AT; Bloom BR
    J Exp Med; 1980 Mar; 151(3):637-50. PubMed ID: 6444662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.
    Lobo-Yeo A; Mieli-Vergani G; Kenna G; Mowat AP; Vergani D
    Clin Exp Immunol; 1987 Nov; 70(2):411-6. PubMed ID: 2448074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BCG-induced chronic pulmonary inflammation and splenomegaly in mice: suppression of PHA-induced proliferation, delayed hypersensitivity to sheep erythrocytes, and chronic pulmonary inflammation by soluble factors from adherent spleen cells.
    Allen EM; Sternick JL; Schrier DJ; Moore VL
    Cell Immunol; 1981 Feb; 58(1):61-71. PubMed ID: 6452952
    [No Abstract]   [Full Text] [Related]  

  • 79. Cellular immune responses during complicated and uncomplicated measles virus infections of man.
    Hirsch RL; Griffin DE; Johnson RT; Cooper SJ; Lindo de Soriano I; Roedenbeck S; Vaisberg A
    Clin Immunol Immunopathol; 1984 Apr; 31(1):1-12. PubMed ID: 6230187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Responses of human T cells to dominant discrete protein antigens of Escherichia coli and Pseudomonas aeruginosa.
    Kersten CM; McCluskey RT; Shaw Warren H; Kurnick JT
    Scand J Immunol; 1994 Aug; 40(2):151-7. PubMed ID: 7519358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.